End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
72 TWD | +0.98% | +5.26% | -4.76% |
05-15 | Polaris Group Voluntarily Withdraws the Phase III Clinical Trial Protocol for Liver Cancer from the FDA | CI |
05-14 | Polaris Group Announces Change of the Member of Compensation Committee | CI |
End-of-day quotes
Sector Other Biotechnology & Medical Research
Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E ratio | |
---|---|---|---|---|---|---|
1.65B | - | - | - | - | - | |
54.63B | - | |||||
39.92B | ||||||
26.86B | ||||||
26.22B | ||||||
18.78B | - |
- Stock Market
- Equities
- 6550 Stock
- Charts Polaris Group
- Sector Chart